| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Former 10% Holder | Director +1 more
3 companies
Mubadala Investment Co Pjsc serves as a Director at AMD and has filed Form 4s across 3 companies. Across recent SEC filings that breaks down to 29 buys and 3 sells. Those positions are worth an estimated $550.0M at current prices.
Historically, Mubadala Investment Co Pjsc's trades have earned a middling insider score of 62/100 across 28 rated trades. Over a 12-month horizon, 96.4% of those trades were profitable, with an average 12-month return of +46.1%.
The biggest single holding is AMD (~$448.5M) as Director. The recent filings there lean toward selling, a net 96,906,166 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 6,300 | $7.95 | $50,059.80 | - | -32.8% | +31.1% | |
| Feb 13, 2023 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 32,474 | $7.97 | $258,837.26 | +0.3% | -29.8% | +22.7% | |
| Feb 10, 2023 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 11,000 | $7.98 | $87,807.50 | - | -34.1% | +23.2% | |
| Feb 1, 2023 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 600 | $7.97 | $4,782.00 | - | -46.7% | +11.7% | |
| Jan 26, 2023 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 7,886 | $7.99 | $63,005.99 | - | -39.3% | +19.4% | |
| Jan 25, 2023 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 24,526 | $7.88 | $193,267.33 | +0.2% | -37.1% | +24.5% | |
| Jan 10, 2023 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 1,029,795 | $7.50 | $7,725,856.82 | +9.1% | -16.3% | +60.3% | |
| Apr 16, 2021 | RXRX Recursion Pharmaceuticals, Inc. | 10% Owner | Buy | 2,777,777 | $18.00 | $49,999,986.00 | New | +3.8% | -79.1% | |
| Feb 5, 2019 | AMD Advanced Micro Devices Inc | Director | Sell | 34,906,166 | $23.43 | $817,851,469.38 | -100% | - | - | |
| Dec 4, 2018 | GAIA Gaia, Inc | Former 10% Holder | Buy | 15,250 | $12.74 | $194,285.00 | +1.2% | - | - |